An interventional study of Iron-folic acid supplement in Iron Deficiency Anemia, sponsored by Johns Hopkins Bloomberg School of Public Health. Completed at 1 site in India. Open to female participants aged 12 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-20.
Sponsored by Johns Hopkins Bloomberg School of Public Health · Not applicable, Interventional, and Prevention
This study will implement and evaluate a community-based intervention to distribute and promote consumption of weekly iron-folic acid supplements and to provide nutrition education to reduce the prevalence of iron deficiency anemia among adolescent girls in West Bengal, India.
644 studies on the registry are indexed under Anemia, Iron-Deficiency; 105 are open to participants now.
This study's planned enrollment of 2,800 is above the median of 100 across 503 interventional studies indexed under Anemia, Iron-Deficiency.
Browse Anemia, Iron-Deficiency studies →Johns Hopkins Bloomberg School of Public Health is the lead sponsor of 364 studies on the registry; 41 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Prevalence of anemia after 1 year of intervention
Knowledge of anemia
Practices regarding treatment and prevention of anemia
Knowledge of iron supplements
Practices regarding iron supplements
Dietary iron intake
This study is completed, as verified in Jan 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Johns Hopkins Bloomberg School of Public Health